| Category: |
siRNA |
| Antibody's target: |
SERPINE1 |
| Immunogen: |
See techfile |
| The antibody was raised in: |
Synthetic |
| Reactivity: |
Mouse, Rat, Human |
| Purification: |
Affinity purified |
| Applications: |
WB (for other see techfile or inquire) |
| Stock availability: |
Shipped within 5-10 working days |
| Storage conditions: |
Avoid repeated freeze/thaw cycles, Aliquot and store at -20 °, C |
| Warnings: |
This product is for research use only |
| Gene target: |
SERPINE1 siRNA |
| Short name: |
Anti-SERPINE1 siRNA |
| Alternative name: |
clade E (nexin, member 1 small interfearing RNA, plasminogen activator inhibitor classification 1), antibody to-serpin peptidase inhibitor |
| Alternative to gene target: |
DNA-templated and biological process this GO :0006367 and transcription initiation from RNA polymerase II promoter and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007596 and blood coagulation and biological process this GO :0010467 and gene expression and biological process this GO :0010469 and regulation of receptor activity and biological process this GO :0010757 and negative regulation of plasminogen activation and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0014912 and negative regulation of smooth muscle cell migration and biological process this GO :0030168 and platelet activation and biological process this GO :0030194 and positive regulation of blood coagulation and biological process this GO :0030195 and negative regulation of blood coagulation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030336 and negative regulation of cell migration and biological process this GO :0031012 and extracellular matrix and cellular component this GO :0031093 and platelet alpha granule lumen and cellular component this GO :0032757 and positive regulation of interleukin-8 production and biological process this GO :0033629 and negative regulation of cell adhesion mediated by integrin and biological process this GO :0035491 and positive regulation of leukotriene production involved in inflammatory response and biological process this GO :0042127 and regulation of cell proliferation and biological process this GO :0042730 and fibrinolysis and biological process this GO :0045087 and innate immune response and biological process this GO :0045765 and regulation of angiogenesis and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0048260 and positive regulation of receptor-mediated endocytosis and biological process this GO :0050729 and positive regulation of inflammatory response and biological process this GO :0050829 and defense response to Gram-negative bacterium and biological process this GO :0051918 and negative regulation of fibrinolysis and biological process this GO :0061044 and negative regulation of vascular wound healing and biological process this GO :0061045 and negative regulation of wound healing and biological process this GO :0071222 and cellular response to lipopolysaccharide and biological process this GO :0090026 and positive regulation of monocyte chemotaxis and biological process this GO :1902042 and negative regulation of extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :2000098 and negative regulation of smooth muscle cell-matrix adhesion and biological process this GO :2000352 and negative regulation of endothelial cell apoptotic process and biological process, Extracellular, PAI and PAI-1 and PAI1 and PLANH1, SERPINE1 and IDBG-32959 and ENSG00000106366 and 5054, SERPINE1 and IDBG-640415 and ENSBTAG00000014465 and 281375, Serpine1 and IDBG-204786 and ENSMUSG00000037411 and 18787, clade E (nexin, member 1, plasminogen activator inhibitor type 1), protein binding, this GO :0001300 and chronological cell aging and biological process this GO :0001525 and angiogenesis and biological process this GO :0002020 and protease binding and molecular function this GO :0002576 and platelet degranulation and biological process this GO :0004867 and serine-type endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006351 and transcription, this GO :0002020 : protease binding, this GO :0002020 : protease binding and also this GO :0004867 : serine-type endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding, this GO :0004867 : serine-type endopeptidase inhibitor activity, this GO :0005102 : receptor binding, this GO :0005515 : protein binding, serpin peptidase inhibitor |
| Identity: |
8583 |
| Gene: |
SERPINE1 |
More about : SERPINE1 |
| Long gene name: |
serpin family E member 1 |
| Synonyms gene: |
PLANH1 PAI1 |
| Synonyms gene name: |
clade E (nexin, clade E (nexin, member 1 , member 1 serpin peptidase inhibitor, plasminogen activator inhibitor type 1), plasminogen activator inhibitor type 1), serine (or cysteine) proteinase inhibitor |
| Synonyms: |
PAI |
| Synonyms name: |
plasminogen activator inhibitor, type I |
| Locus: |
7q22, 1 |
| Discovery year: |
1986-01-01 |
| GenBank acession: |
M16006 |
| Entrez gene record: |
5054 |
| Pubmed identfication: |
3097076 2891140 24172014 |
| RefSeq identity: |
NM_000602 |
| Classification: |
Serpin peptidase inhibitors |
| Havana BLAST/BLAT: |
OTTHUMG00000157107 |
| Locus Specific Databases: |
LRG_597 |